Top Markets
Coin of the day
Arovella Therapeutics Limited Arovella Therapeutics Limited

Arovella Therapeutics Limited

ALA
Peringkat dalam Saham #24896
Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated... Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated to developing therapeutic solutions for oncology and central nervous system afflictions, operating both domestically and internationally. Its pipeline features several key assets, including ZolpiMist, an oral spray formulation of zolpidem tartrate for the treatment of short-term insomnia, commercially known by brands such as Ambien or Stilnox. The company is also advancing an invariant natural killer T (iNKT) cell therapy platform specifically designed to target blood cancers. Furthermore, Arovella employs OroMist, an oro-mucosal technology enabling the delivery of various drug classes through absorption in the oral cavity via the cheeks, gums, tongue, or mouth floor, and is developing Anagrelide for cancer treatment. Beyond these, the company is engaged in creating oral sprays to address conditions like migraine headaches, motion sickness, and drug-resistant epilepsy. Arovella maintains a research collaboration agreement with Imperial College London. Established in 1999 and based in Osborne Park, Australia, the company was formerly known as Suda Pharmaceuticals Ltd before rebranding to Arovella Therapeutics Limited in October 2021.
Harga Saham
$0.04584351
Kapitalisasi Pasar
$55.42M
Perubahan (1 hari)
1.56%
Perubahan (1 tahun)
-16.04%
Negara
AU
Perdagangan Arovella Therapeutics Limited (ALA)

Kategori

Riwayat harga saham Arovella Therapeutics Limited (ALA)
Harga penutupan tertinggi: $0.04 pada 2026-08-01

Harga penutupan terendah: $1.48 pada 2002-01-01
Riwayat harga saham Arovella Therapeutics Limited dari 2002 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 8.84%
2025 -52.69%
2024 61.67%
2023 305.30%
2022 -35.55%
2021 -8.52%
2020 -23.02%
2019 -54.20%
2018 -63.30%
2017 -14.45%
2016 -33.47%
2015 -53.40%
2014 -26.75%
2013 93.13%
2012 59.05%
2011 -63.96%
2010 4.61%
2009 -5.73%
2008 -54.25%
2007 47.42%
2006 0.76%
2005 -54.49%
2004 -35.11%
2003 206.90%
2002 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US